Circulating Tumour DNA (ctDNA) Clearance With Neoadjuvant Durvalumab (D) + Tremelimumab (T) + Enfortumab Vedotin (EV) for Cisplatin-Ineligible Treatment of Muscle-Invasive Bladder Cancer(MIBC) From the Safety Run-in Cohort of the Phase 3 VOLGA Trial Grail Content Editor Circulating Tumour DNA (ctDNA) Clearance With Neoadjuvant Durvalumab (D) + Tremelimumab (T) + Enfortumab Vedotin (EV) for Cisplatin-Ineligible Treatment of Muscle-Invasive Bladder Cancer(MIBC) From the Safety Run-in Cohort of the Phase 3 VOLGA Trial Read More »
Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC Grail Content Editor Clinical Utility of Tumor-Naïve Pre-surgical ctDNA Detection in Early-stage NSCLC Read More »
Prognostic Implication of Methylation-Based Circulating Tumor DNA Detection Prior to Surgery in Stage I Non-Small Cell Lung Cancer Grail Content Editor Prognostic Implication of Methylation-Based Circulating Tumor DNA Detection Prior to Surgery in Stage I Non-Small Cell Lung Cancer Read More »
Identification of Cancer Subtypes With a ctDNA-Based Targeted Methylation Assay Grail Content Editor Click to view poster Identification of Cancer Subtypes With a ctDNA-Based Targeted Methylation Assay Read More »
A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns Grail Content Editor A Novel Tissue-Free Method to Estimate Tumor-Derived Cell-Free DNA Quantity Using Tumor Methylation Patterns Read More »
Analytical validation of a tissue-free, multi-cancer, post-diagnosis cancer research test that uses cell-free DNA methylation profiling Grail Content Editor Analytical validation of a tissue-free, multi-cancer, post-diagnosis cancer research test that uses cell-free DNA methylation profiling Read More »
Utility of ctDNA-based Targeted Methylation MRD Assay for Hematological Malignancies Grail Content Editor Utility of ctDNA-based Targeted Methylation MRD Assay for Hematological Malignancies Read More »
Prediction of the risk of recurrence in patients with non-small-cell lung cancer using an integrated claims and electronic medical record database Grail Content Editor Prediction of the risk of recurrence in patients with non-small-cell lung cancer using an integrated claims and electronic medical record database Read More »
Targeted methylation analysis of circulating cell-free DNA to predict outcomes in clinical stage I NSCLC patients Grail Content Editor Targeted methylation analysis of circulating cell-free DNA to predict outcomes in clinical stage I NSCLC patients Read More »